CagriSema is an investigational clinical program.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
CagriSema is an investigational clinical program. No seller listing in Ireland can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Resolve the exact identity of CagriSema through REDEFINE 1 Phase 3 study - NCT05567796 from ClinicalTrials.gov. Then search Find a medicine for human use from Health Products Regulatory Authority for the destination product record and PSI public registers from Pharmaceutical Society of Ireland for the seller, establishment, or supply route in Ireland. A match in one record does not replace the other two checks.
No. A page using the name CagriSema, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Ireland, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
2 study records currently list 15 locations in this country, including 0 locations individually marked Recruiting.
Registry update: 24 July 2026CagriSema is an investigational clinical program. No seller listing in Ireland can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.
Primary identity source: REDEFINE 1 Phase 3 study - NCT05567796 / ClinicalTrials.gov ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
REDEFINE 1 Phase 3 study - NCT05567796 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open REDEFINE 1 Phase 3 study - NCT05567796 ↗Find a medicine for human use is maintained by Health Products Regulatory Authority. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Find a medicine for human use ↗PSI public registers is maintained by Pharmaceutical Society of Ireland. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open PSI public registers ↗Irish search results can combine authorized medicines, registered pharmacies, clinic services, non-prescription internet suppliers, cross-border websites, and research products. HPRA and PSI maintain separate records for the product and the supply identity.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use HPRA's human-medicine lists to match the exact authorized or withdrawn product, holder, authorization number, strength, form, and current product documents.
Check the pharmacy, pharmacist, and internet-supply records for the legal name and current registration status behind the website or service being reviewed.
PSI states that Irish online supply is limited to non-prescription medicines and registered sites must appear on the Internet Supply List and display a common logo linked to that entry.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.